MSAM
VRTX icon

Moloney Securities Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Moloney Securities Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$572K Sell
1,461
-37
-2% -$15.5K 0.07% 261
2025
Q2 		$667K Sell
1,498
-300
-17% -$138K 0.08% 227
2025
Q1 		$872K Buy
1,798
+65
+4% +$30.3K 0.12% 188
2024
Q4 		$698K Sell
1,733
-149
-8% -$69.1K 0.09% 223
2024
Q3 		$875K Sell
1,882
-72
-4% -$34.6K 0.12% 209
2024
Q2 		$916K Sell
1,954
-11
-0.6% -$4.78K 0.13% 180
2024
Q1 		$821K Sell
1,965
-7
-0.4% -$2.96K 0.12% 196
2023
Q4 		$802K Sell
1,972
-330
-14% -$122K 0.13% 193
2023
Q3 		$800K Sell
2,302
-2,447
-52% -$856K 0.14% 178
2023
Q2 		$1.67M Sell
4,749
-249
-5% -$83.9K 0.3% 84
2023
Q1 		$1.57M Sell
4,998
-69
-1% -$20.7K 0.29% 90
2022
Q4 		$1.46M Sell
5,067
-190
-4% -$57.9K 0.32% 89
2022
Q3 		$1.52M Buy
5,257
+2
+0% +$575 0.37% 72
2022
Q2 		$1.48M Sell
5,255
-525
-9% -$141K 0.35% 79
2022
Q1 		$1.51M Sell
5,780
-1,364
-19% -$324K 0.29% 94
2021
Q4 		$1.57M Buy
+7,144
New +$1.39M 0.27% 87

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Moloney Securities Asset Management's VRTX Position: Q3 2025 in Review

Moloney Securities Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.5% in Q3 2025, selling an estimated $15.5K and leaving 1,461 shares worth $572K. The position accounts for 0.07% of the portfolio, ranked #261.

Moloney Securities Asset Management first reported a position in VRTX in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.67M in Q2 2023. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Moloney Securities Asset Management held 1,461 shares of Vertex Pharmaceuticals worth $572K as of Q3 2025.
  • Moloney Securities Asset Management sold 37 Vertex Pharmaceuticals shares in Q3 2025, an estimated $15.5K.
  • Vertex Pharmaceuticals made up 0.07% of Moloney Securities Asset Management's portfolio in Q3 2025, its #261 holding.
  • Moloney Securities Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Moloney Securities Asset Management's Vertex Pharmaceuticals position peaked at $1.67M in Q2 2023.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.